Publications by authors named "Andrean Husin"

Bisphenols are mainly used as protective coatings for plastics and resin-based materials in various consumer products. Industrial producers have a high demand for bisphenol A (BPA) among all bisphenol substitutes for various consumer products. However, according to reports, prolonged exposure to BPA can cause multiple health issues, including neurodevelopmental disorders in young children.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how prenatal exposure to bisphenol A (BPA) affects the learning and memory abilities of offspring by looking at changes in specific microRNAs and NMDA receptor subunits in the brain.
  • - Pregnant rats were given BPA during gestation, and the offspring were later assessed for gene expression and memory functions at various developmental stages.
  • - Results showed that BPA exposure led to decreased expression of key microRNAs and NMDA receptor proteins, causing significant deficits in spatial and fear memory in adolescent rats.
View Article and Find Full Text PDF

Glutamate receptors are the integral cellular components associated with excitotoxicity mechanism induced by the ischemic cascade events. Therefore the glutamate receptors have become the major molecular targets of neuroprotective agents in stroke researches. Recent studies have demonstrated that a Group I metabotropic glutamate receptor agonist, (S)-3,5-dihydroxyphenylglycine ((S)-3,5-DHPG) preconditioning elicits neuroprotection in the hippocampal slice cultures exposed to toxic level of N-methyl-d-aspartate (NMDA).

View Article and Find Full Text PDF

The use of intravascular hypothermia in the treatment of hemorrhagic stroke is currently still being researched. The exact therapeutic properties and effect of hypothermia on the natural progression of the disease are not known, and a only small number of papers has been published with results from these studies. Mild hypothermia at 34°C was induced in six patients with hemorrhagic stroke in the first 48 h after presentation, using an intravascular catheter placed in the inferior vena cava.

View Article and Find Full Text PDF